MedTrace Logo

Defining Endpoints in Becker Muscular Dystrophy

NCT05257473 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-06-08

No results posted yet for this study

Summary

This is a 24-month, observational study of 50 participants with Becker muscular dystrophy (BMD)

Conditions

  • Becker Muscular Dystrophy
  • Muscular Dystrophies
  • Muscular Dystrophy in Children
  • Muscular Dystrophy, Becker

Sponsors & Collaborators

  • Edgewise Therapeutics, Inc.

    collaborator INDUSTRY

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Nicholas E. Johnson, MD · Virginia Commonwealth University

Eligibility

Min Age
6 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-13
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States
  • New Zealand
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05257473 on ClinicalTrials.gov